Zobrazeno 1 - 10
of 32
pro vyhledávání: '"M. Diocee"'
Publikováno v:
Cancer Research. 81:PS4-26
Background: Developed with retrospective data, the 21-gene recurrence score assay (RS) reduces adjuvant chemotherapy (CTx) use in hormone-positive (HR+), HER2-negative, node-negative breast cancer, justifying the assay’s cost. The TAILORx trial pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df531891c9269eb3b1575075fa240fbb
https://doi.org/10.1158/1538-7445.sabcs20-ps4-26
https://doi.org/10.1158/1538-7445.sabcs20-ps4-26
Autor:
Alan Nichol, Caroline Speers, Stuart Peacock, Megan E. Tesch, Rekha M. Diocee, Caroline Lohrisch, Lovedeep Gondara
Publikováno v:
CancerReferences. 128(4)
BACKGROUND The trial assigning individualized options for treatment (Rx) (TAILORx) confirmed the predictive value of the 21-gene recurrence score (RS) assay in hormone receptor (HR)-positive, HER2-negative, node-negative breast cancer and established
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5174bd060aab510921637f93658eb37b
https://pubmed.ncbi.nlm.nih.gov/34855202
https://pubmed.ncbi.nlm.nih.gov/34855202
Autor:
Caroline Speers, Lovedeep Gondara, J Sun, Stephen Chia, Caroline A. Lohrisch, Nathalie LeVasseur, Rekha M. Diocee
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 146:529-536
Achieving a pathologic complete response (pCR) has been associated with improved long-term outcomes in clinical trials. However, the benefit of achieving pCR across subtypes and its prognostic effect on real-world outcomes has not been well described
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e146c8f9e9e9575ff8c7a27d16d2e87
https://doi.org/10.1007/s00432-019-03083-y
https://doi.org/10.1007/s00432-019-03083-y
Autor:
Winson Y. Cheung, Zachary William Neil Veitch, Stephen Chia, Christine E. Simmons, Rekha M. Diocee, Nathalie LeVasseur, S Lupichuk, Karen King, Pa Tang, R Cossetti, Karen A. Gelmon, OF Khan, Lovedeep Gondara
Publikováno v:
Cancer Research. 79:P1-13
Background: Adjuvant chemotherapy combining anthracyclines and taxanes for early stage breast cancer (ESBC) have demonstrated disease-free survival (DFS) and overall survival (OS) benefits. Among the 3rd generation regimens, 2 options have been favou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0197fcbbb85cbcbf0c73e2b54ceee7d5
https://doi.org/10.1158/1538-7445.sabcs18-p1-13-02
https://doi.org/10.1158/1538-7445.sabcs18-p1-13-02
Autor:
Alan Nichol, Lovedeep Gondara, E.S. Wai, Rekha M. Diocee, Caroline Speers, Pauline T. Truong, Héctor A. Velásquez García, Sarah Hamilton
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 103:381-388
The optimal treatment for patients with extensive pure ductal carcinoma in situ (DCIS) ≥4 cm is controversial. This study evaluates local relapse according to type of local therapy: mastectomy, breast-conserving surgery (BCS) alone, and BCS + radia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46f6f20102e46b7c7d188b92971098f9
https://doi.org/10.1016/j.ijrobp.2018.09.022
https://doi.org/10.1016/j.ijrobp.2018.09.022
Autor:
Rekha M. Diocee, Lovedeep Gondara, J Sun, Caroline Speers, Caroline A. Lohrisch, Stephen Chia
Publikováno v:
Cancer Research. 77:P5-16
Background: Neoadjuvant chemotherapy is a treatment option for breast cancer patients (pts) with locally advanced disease and for pts with operable breast cancer who desire breast conservation. Neoadjuvant therapy also allows for early evaluation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e79847b6d7687db045d5c67b30c915cf
https://doi.org/10.1158/1538-7445.sabcs16-p5-16-17
https://doi.org/10.1158/1538-7445.sabcs16-p5-16-17
Autor:
Caroline Lohrisch, Caroline Speers, Rekha M. Diocee, Sara Kristina Taylor, Alan Nichol, Dan Le, Kirsten Allen
Publikováno v:
Journal of Clinical Oncology. 39:543-543
543 Background: We sought to explore the impact of locoregional recurrence (LRR) on survival in breast cancer (BC) patients in British Columbia treated in the modern era. Methods: A retrospective cohort study design identified patients diagnosed with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0969929ef56e66d57ed79f61adba04b4
https://doi.org/10.1200/jco.2021.39.15_suppl.543
https://doi.org/10.1200/jco.2021.39.15_suppl.543
Autor:
Rinat Yerushalmi, Caroline Lohrisch, Nathalie LeVasseur, Hiten Naik, Caroline Speers, Lovedeep Gondara, Rekha M. Diocee, Karen A. Gelmon
Publikováno v:
Journal of Clinical Oncology. 39:e18791-e18791
e18791 Background: Patients with HER2 positive early-stage breast cancer (ESBC) with residual disease (RD) following neoadjuvant therapy derive benefit from treatment escalation. However, treatment modifications for patients who achieve a complete pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::562e1f1cf4a9bbcc31d419f443c952cd
https://doi.org/10.1200/jco.2021.39.15_suppl.e18791
https://doi.org/10.1200/jco.2021.39.15_suppl.e18791
Autor:
Caroline Lohrisch, Maryam Dosani, Alan Nichol, Rekha M. Diocee, Caroline Speers, Sarah Hamilton, Pauline T. Truong, Lovedeep Gondara
Publikováno v:
Radiotherapy and Oncology. 139:S25-S26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48bd9accdfb762728d2bc0af0c3e6778
https://doi.org/10.1016/s0167-8140(19)33341-9
https://doi.org/10.1016/s0167-8140(19)33341-9
Autor:
Stephen Chia, Alan Nichol, Lovedeep Gondara, Caroline Speers, Christine Simmons, Caroline A. Lohrisch, J Sun, Rekha M. Diocee, Nathalie LeVasseur
Publikováno v:
Journal of Clinical Oncology. 37:e12100-e12100
e12100 Background: The use of neoadjuvant treatment has increased over the past decade due to its ability to assess tumour sensitivity to systemic treatment in vivo, and to downstage women for increased breast conserving surgery. Recent studies have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7d6444835f2256a16f23dd5c3b22590
https://doi.org/10.1200/jco.2019.37.15_suppl.e12100
https://doi.org/10.1200/jco.2019.37.15_suppl.e12100